CIBMTR Reporting Implementation Guide
0.1.4 - Trial Use 1
This page is part of the CIMBTRReporting (v0.1.4: Trial Use 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions
{
"resourceType" : "CodeSystem",
"id" : "cibmtr-cadsr-cde",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system http://cdebrowser.nci.nih.gov defines many codes, of which the following are a subset:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">CADSR:2603692<a name=\"cibmtr-cadsr-cde-CADSR.582603692\"> </a></td><td>Acute Graft Versus Host Disease Maximum Overall Grade</td></tr><tr><td style=\"white-space:nowrap\">CADSR:2626409<a name=\"cibmtr-cadsr-cde-CADSR.582626409\"> </a></td><td>Biopsy Anatomic Site Performed Name</td></tr><tr><td style=\"white-space:nowrap\">CADSR:2797618<a name=\"cibmtr-cadsr-cde-CADSR.582797618\"> </a></td><td>Acute Graft Versus Host Disease Skin Involvement Maximum Severity Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:2797633<a name=\"cibmtr-cadsr-cde-CADSR.582797633\"> </a></td><td>Acute Graft Versus Host Disease Lower Gastrointestinal Tract Involvement Maximum Severity Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:2797671<a name=\"cibmtr-cadsr-cde-CADSR.582797671\"> </a></td><td>Acute Graft Versus Host Disease Liver Involvement Maximum Severity Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:2980753<a name=\"cibmtr-cadsr-cde-CADSR.582980753\"> </a></td><td>Therapeutic Procedure Administered Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:3005293<a name=\"cibmtr-cadsr-cde-CADSR.583005293\"> </a></td><td>Graft Versus Host Disease Diagnosis Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:5040179<a name=\"cibmtr-cadsr-cde-CADSR.585040179\"> </a></td><td>Acute Graft Versus Host Disease Stage Upper Gastrointestinal Tract Severity Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:5263856<a name=\"cibmtr-cadsr-cde-CADSR.585263856\"> </a></td><td>Post Infusion Procedure Timepoint Type</td></tr><tr><td style=\"white-space:nowrap\">CADSR:6975011<a name=\"cibmtr-cadsr-cde-CADSR.586975011\"> </a></td><td>Concomitant Medication Use Indication Reason</td></tr></table></div>"
},
"url" : "http://cdebrowser.nci.nih.gov",
"version" : "0.1.4",
"name" : "CADSR_CDE_CS",
"title" : "NIH Common Data Elements for CIBMTR",
"status" : "active",
"experimental" : false,
"date" : "2021-06-25T13:41:27-05:00",
"publisher" : "The Medical College of Wisconsin, Inc. and the National Marrow Donor Program",
"contact" : [
{
"name" : "The Medical College of Wisconsin, Inc. and the National Marrow Donor Program",
"telecom" : [
{
"system" : "url",
"value" : "http://www.cibmtr.org"
}
]
},
{
"name" : "Bob Milius",
"telecom" : [
{
"system" : "email",
"value" : "bmilius@nmdp.org"
}
]
}
],
"description" : "NIH Common Data Elements for CIBMTR",
"copyright" : "National Cancer Institute (NCI)",
"content" : "fragment",
"concept" : [
{
"code" : "CADSR:2603692",
"display" : "Acute Graft Versus Host Disease Maximum Overall Grade"
},
{
"code" : "CADSR:2626409",
"display" : "Biopsy Anatomic Site Performed Name"
},
{
"code" : "CADSR:2797618",
"display" : "Acute Graft Versus Host Disease Skin Involvement Maximum Severity Type"
},
{
"code" : "CADSR:2797633",
"display" : "Acute Graft Versus Host Disease Lower Gastrointestinal Tract Involvement Maximum Severity Type"
},
{
"code" : "CADSR:2797671",
"display" : "Acute Graft Versus Host Disease Liver Involvement Maximum Severity Type"
},
{
"code" : "CADSR:2980753",
"display" : "Therapeutic Procedure Administered Type"
},
{
"code" : "CADSR:3005293",
"display" : "Graft Versus Host Disease Diagnosis Type"
},
{
"code" : "CADSR:5040179",
"display" : "Acute Graft Versus Host Disease Stage Upper Gastrointestinal Tract Severity Type"
},
{
"code" : "CADSR:5263856",
"display" : "Post Infusion Procedure Timepoint Type"
},
{
"code" : "CADSR:6975011",
"display" : "Concomitant Medication Use Indication Reason"
}
]
}